[Federal Register Volume 68, Number 238 (Thursday, December 11, 2003)]
[Notices]
[Pages 69087-69088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-30719]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Drug Resistance.
    Date: December 11, 2003.
    Time: 2:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone conference call).
    Contact Person: Marcia Litwack, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6206, MSC 7804, Bethesda, MD 
20892. (301) 435-1719.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, ZRG1 SSS-5 (06) M: PKD Studies.
    Date: December 17, 2003.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone conference call).
    Contact Person: M. James Scherbenske, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 
20892. 301-435-1173.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, ZRG 1 SSS-5 (04) M: Transport Studies.
    Date: December 18, 2003.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone conference call).
    Contact Person: Contact Person: M. James Scherbenske, PhD, 
Scientific Review Administrator, Center for Scientific Review, 
National Institutes of Health, 6701 Rockledge Drive, Room 4108, MSC 
7814, Bethesda, MD 20892. 301-435-1173.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, APO E and Gamma Secretases.
    Date: January 6, 2004.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 69088]]

    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone conference call).
    Contact Person: Carl D. Banner, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4138, MSC 7850, Bethesda, MD 
20892. (301) 435-1251. [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: December 4, 2003.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-30719 Filed 12-10-03; 8:45 am]
BILLING CODE 4140-01-M